A major recall of thousands of bottles of medication has been upgraded to a higher risk level.
In September, a U.S. Food and Drug Administration Enforcement Report announced that Ascend Laboratories was recalling 141,984 bottles of its Atorvastatin Calcium Tablets, a medication used to lower cholesterol. The recall is due to “failed dissolution specifications,” which is when a drug does not dissolve the way it was supposed to during laboratory testing.
